Discover 486 paid clinical trials in Rhode Island. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Rhode Island offers a variety of research opportunities for healthy individuals looking to volunteer in paid studies and those with specific health conditions alike. Research centers in Providence, Warwick, and Cranston are actively recruiting participants, providing access to advanced treatments and top-tier healthcare.
Filter
1
Filter results
Results: 486
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
for
Meningioma
Location: Boston MA, Providence RI, New York NY, Fairfax VA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07428616
Phase 2, Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia
Location: Halifax, Providence RI, New Haven CT, Lake Success NY,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18 - 39
Code: NCT03150693
Phase 3, Recruiting
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
for
Type 2 Diabetes
Location: East Greenwich RI, Burke VA, Midlothian VA, Miami FL,
Sponsor: Housey Healthcare ULC
Sex: All
Age: 18+
Code: NCT07546929
Phase 2, Recruiting
Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours
for
Solid Tumours
Location: Providence RI, New York NY, Fairfax VA, Houston TX
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07446855
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Location: Providence RI, Teaneck NJ, Syracuse NY, Fairfax VA,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT07024784
Phase 2, Recruiting
Rhode Island Community-based Maternal Support Services
for
Perinatal Outcomes, Social Determinants of Health (SDOH),
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island
Sex: Female
Age: 0+
Code: NCT07446374
Recruiting
Pilot Trial of Supplemental Vitamin A and Nicotinamide
for
Skin Cancer, Kidney Transplant Recipients
Location: Providence RI
Sponsor: Rhode Island Hospital
Sex: All
Age: 18+
Code: NCT05702398
Early Phase 1, Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
for
Ovarian Neoplasms, Ovarian Cancer
Location: Scarborough ME, Providence RI, Chicoutimi, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07318558
Phase 3, Recruiting
Cognitive Rehabilitation for Veterans With PNES
for
Psychogenic Nonepileptic Seizures (PNES)
Location: Providence RI
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT07316543
Recruiting
Adolescent Stress and Substance Intervention Subsequent to Trauma
for
PTSD, Substance Use Disorder (SUD), Acute Stress Disorder
Location: Providence RI
Sponsor: Rhode Island Hospital
Sex: All
Age: 12 - 17
Code: NCT07197476
Recruiting
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
for
Fibromyalgia
Location: North Dartmouth MA, Boston MA, Watertown MA,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07398417
Phase 3, Recruiting
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
for
Gastric Adenocarcinoma,
Location: Westerly RI, Waterford CT, Guilford CT, North Haven CT,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT07001748
Phase 2, Phase 3, Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)